Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New 11-beta-HSD1 inhibitors developed at High Point Pharmaceuticals

Feb. 27, 2012

SK Biopharmaceuticals begin U.S. phase II trial of SKL-11197

Feb. 24, 2012

FDA advisory committee recommends approval of obesity therapy

Feb. 23, 2012

NICE confirms guidance on prolonged-release exenatide for type 2 diabetes

Feb. 23, 2012

Novel diacylglycerol O-acyltransferase 1 inhibitors synthesized

Feb. 23, 2012

Critical Pharma and U.K. university team up to develop nasal spray for osteoporosis

Feb. 21, 2012

Novel diacylglycerol O-acyltransferase 1 inhibitors synthesized by Sanofi

Feb. 21, 2012

FDA approves first medical therapy for endogenous Cushing's syndrome

Feb. 20, 2012

CHMP recommends approval of Byetta line extension

Feb. 20, 2012

Hyundai Pharmaceutical discloses new GPR119 receptor agonists

Feb. 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...